Human infection by the gastric pathogen Helicobacter pylori is characterized by a robust immune response which rarely prevents persistent H. pylori colonization. Emerging evidence suggests that lactobacilli may reduce H. pylori infection rates and associated inflammation. In this study, we measured the ability of two model strains of Lactobacillus salivarius (UCC118 and UCC119) to modulate gastric epithelial cell chemokine responses to H. pylori infection. Pre-treatment of AGS cells with either L. salivarius strain significantly decreased interleukin-8 (IL-8) production upon exposure to H. pylori, but not in cells stimulated with TNF-α. The production of the chemokines CCL20 and IP-10 by AGS cells infected with H. pylori was also altered following pre-treatment with UCC118 and UCC119. We showed that a greater reduction in IL-8 production with UCC119 was due to the production of more acid by this strain. Furthermore, UV-killed cells of both lactobacillus strains were still able to reduce H. pylori-induced IL-8 in the absence of acid production, indicating the action of a second anti-inflammatory mechanism. This immunomodulatory activity was not dependent on adhesion to epithelial cells or bacteriocin production. Real-time RT-PCR analysis showed that expression of eight of twelve Cag pathogenicity island genes tested was downregulated by exposure to L. salivarius, but not by cells of four other lactobacillus species. CagA accumulated in H. pylori cells following exposure to L. salivarius presumably as a result of loss of functionality of the Cag secretion system. These data identified a new mechanism whereby some probiotic bacteria have a positive effect on H. pylori-associated inflammation without clearing the infection.
BikE. M.,
EckburgP. B.,
GillS. R.,
NelsonK. E.,
PurdomE. A.,
FrancoisF.,
Perez-PerezG.,
BlaserM. J.,
RelmanD. A.2006; Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A 103:732–737[CrossRef]
BourzacK. M.,
BothamC. M.,
GuilleminK.2007; Helicobacter pylori CagA induces AGS cell elongation through a cell retraction defect that is independent of Cdc42, Rac1, and Arp2/3. Infect Immun 75:1203–1213[CrossRef]
BrandtS.,
KwokT.,
HartigR.,
KonigW.,
BackertS.2005; NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci U S A 102:9300–9305[CrossRef]
ClaessonM. J.,
LiY.,
LeahyS.,
CanchayaC.,
van PijkerenJ. P.,
Cerdeño-TárragaA. M.,
ParkhillJ.,
FlynnS.,
O'SullivanG. C.other authors2006; Multireplicon genome architecture of Lactobacillus salivarius
. Proc Natl Acad Sci U S A 103:6718–6723[CrossRef]
CorrS. C.,
LiY.,
RiedelC. U.,
O'TooleP. W.,
HillC.,
GahanC. G.2007; Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci U S A 104:7617–7621[CrossRef]
CorsettiA.,
SettanniL.,
Van SinderenD.2004; Characterization of bacteriocin-like inhibitory substances (BLIS) from sourdough lactic acid bacteria and evaluation of their in vitro and in situ activity. J Appl Microbiol 96:521–534[CrossRef]
De VriesA. C.,
Van DrielH. F.,
RichardusJ. H.,
OuwendijkM.,
Van VuurenA. J.,
De ManR. A.,
KuipersE. J.2008; Migrant communities constitute a possible target population for primary prevention of Helicobacter pylori -related complications in low incidence countries. Scand J Gastroenterol 43:403–409
DufourJ. H.,
DziejmanM.,
LiuM. T.,
LeungJ. H.,
LaneT. E.,
LusterA. D.2002; IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 168:3195–3204[CrossRef]
DunneC.,
O'MahonyL.,
MurphyL.,
ThorntonG.,
MorrisseyD.,
O'HalloranS.,
FeeneyM.,
FlynnS.,
FitzgeraldG.other authors2001; In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr 73:386S–392S
FischerW.,
PulsJ.,
BuhrdorfR.,
GebertB.,
OdenbreitS.,
HaasR.2001; Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol 42:1337–1348
GrahamD. Y.,
ShiotaniA.2008; New concepts of resistance in the treatment of Helicobacter pylori infections. Nat Clin Pract Gastroenterol Hepatol 5:321–331[CrossRef]
HigashiH.,
TsutsumiR.,
FujitaA.,
YamazakiS.,
AsakaM.,
AzumaT.,
HatakeyamaM.2002; Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A 99:14428–14433[CrossRef]
JelcicI.,
HufnerE.,
SchmidtH.,
HertelC.2008; Repression of the LEE-encoded regulator gene transcription of E. coli O157 : H7 by culture supernatants of Lactobacillus reuteri is LuxS and strain dependent. Appl Environ Microbiol 74:3310–3314[CrossRef]
MoeseS.,
SelbachM.,
Zimny-ArndtU.,
JungblutP. R.,
MeyerT. F.,
BackertS.2001; Identification of a tyrosine-phosphorylated 35 kDa carboxy-terminal fragment (p35CagA) of the Helicobacter pylori CagA protein in phagocytic cells: processing or breakage?. Proteomics 1:618–629[CrossRef]
NevilleL. F.,
MathiakG.,
BagasraO.1997; The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine Growth Factor Rev 8:207–219[CrossRef]
O'TooleP. W.,
JanzonL.,
DoigP.,
HuangJ.,
KostrzynskaM.,
TrustT. J.1995; The putative neuraminyllactose-binding hemagglutinin HpaA of Helicobacter pylori CCUG 17874 is a lipoprotein. J Bacteriol 177:6049–6057
RobinsonK.,
ArgentR. H.,
AthertonJ. C.2007; The inflammatory and immune response to Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 21:237–259[CrossRef]
RokkaS.,
MyllykangasS.,
JoutsjokiV.2008; Effect of specific colostral antibodies and selected lactobacilli on the adhesion of Helicobacter pylori on AGS cells and the Helicobacter -induced IL-8 production. Scand J Immunol 68:280–286[CrossRef]
RyanK. A.,
van DoornL. J.,
MoranA. P.,
GlennonM.,
SmithT.,
MaherM.2001; Evaluation of clarithromycin resistance and cagA and vacA genotyping of Helicobacter pylori strains from the west of Ireland using line probe assays. J Clin Microbiol 39:1978–1980[CrossRef]
RyanK. A.,
DalyP.,
LiY.,
HootonC.,
O'TooleP. W.2008a; Strain-specific inhibition of Helicobacter pylori by Lactobacillus salivarius and other lactobacilli. J Antimicrob Chemother 61:831–834[CrossRef]
RyanK. A.,
JayaramanT.,
DalyP.,
CanchayaC.,
CurranS.,
FangF.,
QuigleyE.,
O'TooleP. W.2008b; Isolation of lactobacilli with probiotic properties from the human stomach. Lett Appl Microbiol 47:269–274[CrossRef]
SharmaS. A.,
TummuruM. K.,
MillerG. G.,
BlaserM. J.1995; Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro
. Infect Immun 63:1681–1687
SteinM.,
RappuoliR.,
CovacciA.2000; Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci U S A 97:1263–1268[CrossRef]
TamuraA.,
KumaiH.,
NakamichiN.,
SugiyamaT.,
DeguchiR.,
TakagiA.,
KogaY.2006; Suppression of Helicobacter pylori -induced interleukin-8 production in vitro and within the gastric mucosa by a live Lactobacillus strain. J Gastroenterol Hepatol 21:1399–1406
TowbinH.,
StaehelinT.,
GordonJ.1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76:4350–4354[CrossRef]
UemuraN.,
OkamotoS.,
YamamotoS.,
MatsumuraN.,
YamaguchiS.,
YamakidoM.,
TaniyamaK.,
SasakiN.,
SchlemperR. J.2001; Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784–789[CrossRef]
van PijkerenJ. P.,
CanchayaC.,
RyanK. A.,
LiY.,
ClaessonM. J.,
SheilB.,
SteidlerL.,
O'MahonyL.,
FitzgeraldG. F.other authors2006; Comparative and functional analysis of sortase-dependent proteins in the predicted secretome of Lactobacillus salivarius UCC118. Appl Environ Microbiol 72:4143–4153[CrossRef]
VelinD.,
BachmannD.,
BouzoureneH.,
MichettiP.2005; Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model. Gastroenterology 129:142–155[CrossRef]